Nimbus Discovery and Proteros Enter into X-Ray Crystallography Agreement
News Nov 09, 2012
Nimbus Discovery LLC, announced that it has executed a Privileged Partnership Agreement with Proteros Biostructures GmbH, Martinsried, Germany.
Nimbus joins a select number of prestigious pharmaceutical and biotechnology companies that have entered into Privileged Partnership Agreements with Proteros. Privileged Partners are able to preferentially access Proteros' new Gallery Structures, technologies and extensive in-house expertise to accelerate structure-based drug discovery efforts.
Jonathan Montagu, Vice President, Business Development and Operations at Nimbus commented, "Our cutting-edge computational platform relies heavily upon high quality x-ray structure data. Hence, our current collaboration with Proteros has been instrumental in our success with previously inaccessible targets. This expanded partnership is a logical progression of how we are integrating leading edge technologies to create a new model for drug discovery."
Cony D'Cruz, Chief Business Officer and President, Proteros, US Inc. added, "We are excited to expand our collaboration with Nimbus. The relationship has been very productive and we look forward to continuing to support Nimbus' innovative and proven discovery platform."